In the US, Quazepam (quazepam systemic) is a member of the drug class benzodiazepines and is used to treat Insomnia.
US matches:
- Quazepam
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05CD10
CAS registry number (Chemical Abstracts Service)
0036735-22-5
Chemical Formula
C17-H11-Cl-F4-N2-S
Molecular Weight
386
Therapeutic Categories
Benzodiazepine derivative
Hypnotic and sedative agent
Chemical Name
2H-1,4-Benzodiazepin-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-
Foreign Names
- Quazepamum (Latin)
- Quazepam (German)
- Quazépam (French)
- Quazepam (Spanish)
Generic Names
- Quazepam (OS: BAN, USAN, DCIT)
- Quazépam (OS: DCF, DCF)
- Sch 16134 (IS: Schering)
- Quazepam (PH: USP 32)
Brand Names
- Doral
Hisamitsu, Japan; Meda, United States; Questcor, United States - Quiedorm
Fermon, Spain
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment